Ferry Service Linking Taiwan and Japans Ishigaki Island Set for Inaugural Voyage Genpact CEO Suggests AI Could Reduce IT Workload and Slow Job Growth Venture Capital Targets Boring Businesses with Thin Margins Using AI and Deal Flow Precious Metals Retreat as US Dollar Strength Persists Key Levels for Potential Recovery BP Sacks Chairman Albert Manifold in Latest Leadership ShakeUp at Energy Giant Bear Call Spread Opportunities Highlighted for May 26 Expiration Cadre Holdings Inc CDRE Q1 2026 Earnings EPS Misses Estimates by 417 Amid Revenue Unavailability Velocity Financial Q1 2026 Earnings EPS Beat Fails to Boost Stock ZS Q1 2026 Earnings EPS Surprises to the Upside Amidst Growth Focus RPAY Q1 2026 Earnings EPS Beat Drives Positive Market Reaction SCHL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Response OKUR Q1 2026 Earnings Wider EPS Loss Underscores Heavy RD Investment as PreRevenue Biotech Advances Pipeline Foremost Clean Energy Warrants Surge FMSTW Climbs Nearly 10 as Momentum Builds Voyager Acquisition Corp VACH Faces Steep Decline Testing Support Levels After 654 Drop Tripcom Group TCOM Edges Higher Amid Steady Uptrend Key Levels in Focus DTE Energy Junior Subordinated Debenture DTW Edges Higher in Quiet Trading EUDA Health Warrants EUDAW Hold Steady at 004 Flat Session Highlights Lack of Catalysts Meta Shares Decline Following Quarterly Results Iran Internet Disruptions Weigh on User Growth Arlo Technologies Q1 2026 Earnings EPS Surges Past Estimates Stock Gains as Profitability Improves Offerpad Solutions OPAD Gains 4 as Housing Market Shifts Key Levels to Watch Verastem Inc Q1 2026 Earnings Narrowerthanexpected loss amid ongoing clinical developments HCWC Q4 2025 Earnings NarrowerthanExpected Loss Per Share Concord Medical Services CCM Q2 2016 Earnings Deep EPS Miss Despite Stock Surge PhenixFIN Corporation 525 Notes due 2028 PFXNZ Q1 2026 Earnings Strong EPS Beat of 2541 Surprise SPAI Q1 2026 Earnings EPS Misses Estimates Amid Revenue Discontinuation HYFM Q3 2025 Earnings Significant EPS Miss Highlights Ongoing Challenges Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues